We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

Share Price Information for Argentex Group. (AGFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 43.70
Ask: 44.90
Change: -1.70 (-3.70%)
Spread: 1.20 (2.746%)
Open: 46.00
High: 46.00
Low: 43.50
Prev. Close: 46.00
AGFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update and Board changes

20 Jan 2021 07:00

RNS Number : 2311M
Argentex Group PLC
20 January 2021
 

20 January 2021

Argentex Group PLC ("Argentex")

Trading update and Board changes

Argentex, the provider of bespoke foreign exchange advisory and execution services to financial institutions, corporates and high net worth individuals today provides a trading update and announces a number of Board changes.

Trading update

Argentex is pleased to report that trading has continued to improve following the announcement of its Interim Results on 20 November 2020. Although the full effect of the latest lockdown has yet to be felt, the recent Brexit trade agreement and the successful implementation of the vaccine programme for Covid-19 provides the Board of Argentex with confidence that this encouraging trend, driven by a return to historic client trading behaviour, will continue for the remainder of the financial year to 31 March 2021.

Board changes

The Board is also pleased to announce the appointment of Jo Stent as Chief Financial Officer with effect from 1 February 2021. She has been a senior finance professional for 25 years, most recently as Chief Financial Officer of the European Tour and Ryder Cup Europe. She is a former CFO of Vodafone Americas having previously held senior positions at Telus Communications and Deloitte. Jo is a chartered accountant having qualified at EY. Jo will replace Sam Williams, who is leaving Argentex to pursue other opportunities, after a handover period of three months.

Carl Jani, Joint CEO, is taking a leave of absence from the business for health reasons with immediate effect. In this interim period, Harry Adams, Joint CEO, will assume the role of sole CEO.

 

Harry Adams, CEO said: "We are delighted to have attracted someone of Jo's calibre to Argentex. Her financial expertise and experience in global businesses will be a huge benefit to us as we continue to realise our growth ambitions. This is an exciting time for us as trading volumes return to pre-pandemic levels."

Lord Digby Jones, Chairman, commented: "I am pleased to welcome Jo to the Board of Argentex where her skills will be a major asset for us as we continue to grow. I'd also like to thank Sam for his dedication and hard work. He joined us in 2015 and was a key member of the team for our successful IPO in 2019. We wish him every success in the future.

"We all wish Carl well and hope he makes a full and speedy recovery."

For further information please contact:

 

FTI Consulting (Financial PR)

Ed Berry / Shiv Talwar / Ambrose Fullalove

Telephone: 07703 330 199

argentex@fticonsulting.com

 

 

Numis Securities Limited (Nominated Adviser and Broker)

Stephen Westgate, Charlie Farquhar, Laura White, Hugo RubinsteinTelephone: +44 (0) 20 7260 1000

 

Additional information:

Joanne Thomson Stent (formerly Fletcher, aged 46) is, or has been, a director or partner of the following companies or partnerships during the previous five years:

 

Current directorships:

Previous directorships (last 5 years):

The National Coaching Foundation

PGA European Tour Productions Limited

 

Fundación Andalusia Valderrama Masters

 

Coachwise Limited

 

Save as set out above there are no other disclosures in respect of the appointment of Jo Stent that fall to be made under Rule 17 or paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBLMPTMTJBBLB
Date   Source Headline
17th Apr 20247:00 amRNSHolding(s) in Company
27th Feb 20247:00 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSHolding(s) in Company
14th Feb 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSHolding(s) in Company
30th Jan 20247:00 amRNSTrading Update and CFO appointment
23rd Nov 20237:00 amRNSDirector/PDMR Dealing
21st Nov 20234:12 pmRNSDirector/PDMR Dealing
16th Nov 20239:23 amRNSAppointment of Non-executive Director
10th Nov 20237:00 amRNSTrading Statement
9th Nov 20233:18 pmRNSStandard form for notification of major holdings
9th Nov 20237:00 amRNSBoard Change
6th Nov 20239:35 amRNSHolding(s) in Company
26th Oct 20237:00 amRNSBoard Change
13th Sep 20237:00 amRNSInterim results for the six months to 30 June 2023
19th Jul 20232:36 pmRNSTR1 Disclosure - Gresham House Asset Management
18th Jul 20237:00 amRNSNotice of Interim Results
12th Jul 202312:55 pmRNSDirector / PDMR Dealing
10th Jul 20237:00 amRNSHalf year trading update and board changes
27th Jun 202312:20 pmRNSTR1 Notification
22nd Jun 20239:46 amRNSResult of AGM
20th Apr 20235:05 pmRNSPublication of Annual Report and Notice of AGM
12th Apr 20237:00 amRNSFull results for the 9 months to 31 December 2022
30th Mar 20237:00 amRNSNotice of Results and Presentations
13th Mar 20237:00 amRNSUpdate on counterparties
28th Feb 20237:00 amRNSBoard Announcement
26th Jan 20237:00 amRNSTrading Statement
12th Dec 20227:00 amRNSTrading Statement
17th Nov 20222:08 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSGrant of Awards Under New LTIP
8th Nov 202212:55 pmRNSNew Long Term Incentive Plan
8th Nov 20227:00 amRNSInterim Results
12th Oct 20227:00 amRNSNotice of Interim Results
3rd Oct 20227:00 amRNSTrading Update
23rd Sep 20226:05 pmRNSHolding(s) in Company
16th Sep 20227:00 amRNSNetherlands Electronic Money Licence granted
9th Sep 20221:10 pmRNSHolding(s) in Company
22nd Aug 20221:59 pmRNSResult of AGM
15th Jul 20227:00 amRNSPublication of Annual Report and Notice of AGM
6th Jul 20227:00 amRNSFull year results for period ended 31 March 2022
31st May 20227:00 amRNSNotice of Results
12th Apr 20227:00 amRNSTrading Update
8th Nov 20217:00 amRNSInterim Results
1st Nov 20217:00 amRNSInterim Results Presentations
11th Oct 20217:00 amRNSTrading Statement
27th Aug 20215:21 pmRNSHolding(s) in Company
13th Aug 20212:16 pmRNSHolding(s) in Company
12th Aug 20214:09 pmRNSHolding(s) in Company
12th Aug 20213:09 pmRNSHolding(s) in Company
12th Aug 20213:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.